产品封面图

Human VEGFD His标签重组血管内皮生长因子D(V

EGF-D)
收藏
  • ¥1855
  • 翌圣生物(Yeasen)已认证
  • 91501ES10
  • 上海翌圣
  • 2025年12月07日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 保质期

      有效期1年

    • 保存条件

      -20℃至-80℃保存

    • 供应商

      翌圣生物科技(上海)股份有限公司

    • 库存

      现货

    • 英文名

      Recombinant Human VEGFD,His tag

    • 规格

      10 μg

    Product Information

    Product Name

    Cat#

    Size

    Price(¥

    Recombinant Human VEGFD,His tag

    91501ES10

    10 μg

    1855.00

    91501ES60

    100 μg

    6885.00

    91501ES80

    1 mg

    29885.00

     

    Product Description

     
    Vascular endothelial growth factor D (VEGF-D), also known as c-fos-induced growth factor (FIGF), is a secreted glycoprotein of the VEGF/PDGF family. VEGFs regulate angiogenesis and lymphangiogenesis during development and tumor growth, and are characterized by eight conserved cysteine residues that form a cystine knot structure. VEGF-C and VEGF-D, which share 23% amino acid (aa) sequence identity, are uniquely expressed as preproproteins that contain long N- and Cterminal propeptide extensions around the VEGF homology domain (VHD). Proteolytic processing of the 354 aa VEGF-D preproprotein creates a secreted proprotein. Further processing by extracellular serine proteases, such as plasmin or furin-like proprotein convertases, forms mature VEGF-D consisting of noncovalently linked 42 kDa homodimers of the 117 aa VHD. Mature human VEGF-D shares 94%, 95%, 99%, 97% and 93% aa identity with mouse, rat, equine, canine and bovine VEGF-D, respectively. It is expressed in adult lung, heart, muscle, and small intestine, and is most abundantly expressed in fetal lungs and skin. Mouse and human VEGF-D are ligands for VEGF Receptor 3 (VEGF R3, also called Flt-4) that are active across species and show enhanced affinity when processed. Processed human VEGF-D is also a ligand for VEGF R2, also called Flk-1 or KDR. VEGF R3 is strongly expressed in lymphatic endothelial cells and is essential for regulation of the growth and differentiation of lymphatic endothelium. While VEGF-C is the critical ligand for VEGF R3 during embryonic lymphatic development, VEGF-D is most active in neonatal lymphatic maturation and bone growth. Both promote tumor lymphangiogenesis .
     
    Product Properties
     
    Synonyms c-fos induced growth factor (vascular endothelial growth factor D); FIGF; vascular endothelial growth factor D; VEGFD; VEGF-D; VEGF-DVEGFDc-Fos-induced growth factor
    Accession O43915
    Source HEK293 Cells-derived human VEGFD, Phe 93-Ser 201 with His tag at the C-terminus
    Molecular Weight The recombinant mature form of human VEGFD consists of 120 amino acids and has a predicted molecular mass of 13.6 kDa. In SDS-PAGE under reducing conditions, it migrates with an apparent molecular mass of 20-22 kDa due to glycosylation.
    Tag His
    Physical Appearance Sterile Filtered White lyophilized (freeze-dried) powder.
    Purity 95% by SDS-PAGE.
    Biological Activity Measured in a cell proliferation assay using human umbilical vein endothelial cells (HUVEC). The ED50 for this effect is 0.31.6 μg/mL.
    Endotoxin < 1.0 EU per 1μg of the protein by the LAL method.
    Formulation Lyophilized from a 0.2 μm filtered concentrated solution in PBS, pH 7.4.
    Reconstitution We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20°C. Further dilutions should be made in appropriate buffered solutions.
    Shipping and Storage
     
    The products are shipped with ice pack and can be stored at -20 ℃ for 1 year.
    1 month, 2 to 8 °C under sterile conditions after reconstitution.
    3 months, -20 °C under sterile conditions after reconstitution.
    Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles.
     
    Cautions
     
    1. Avoid repeated freeze-thaw cycles.
    2. For your safety and health, please wear lab coats and disposable gloves for operation.
    3. For research use only.

    HB221025

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • 血管内皮生长因子D(VEGF-D)酶联免疫分析(ELISA)

      血管内皮生长因子D(VEGF-D) 酶联免疫分析(ELISA ) 试剂盒使用说明书 本试剂仅供研究使用         目的:本试剂盒用于测定人血清,血浆及相关液体样本中 血管内皮生长因子D(VEGF-D) 的 含量。 实验原理:   本试剂盒应用双抗体夹心法测定标本中 人 血管内皮生长因子D(VEGF-D) 水平。用纯化的 人 血管内皮生长因子D(VEGF-D) 抗体包被微孔板,制成固相抗体,往包被单抗的微孔中

    • 血管内皮生长因子-D(VEGF-D)ELISA试剂盒 说明书

        上海西唐生物科技有限公司   021-55229872,  65333639   www.westang.com 人血管内皮生长因子-D ( VEGF-D )ELISA 试剂盒   ( 用于血清、血浆、细胞培养上清液和其它生物体液内 )   原理 本实验采用双抗体夹心  ABC-ELISA 法。用抗人   VEGF-D   单抗包被于酶标板上,标准品和样品中的   VEGF-D与单抗结合,加入

    • 小鼠血管内皮生长因子-D(VEGF-D)ELISA试剂盒 说明书

        上海西唐生物科技有限公司   021-55229872,  65333639   www.westang.com 小鼠血管内皮生长因子-D ( VEGF-D )ELISA 试剂盒   ( 用于血清、血浆、细胞培养上清液和其它生物体液内 )   原理 本实验采用双抗体夹心  ABC-ELISA 法。用抗小鼠   VEGF-D   单抗包被于酶标板上,标准品和样品中的   VEGF-D与单抗结合

    图标技术资料

    需要更多技术资料 索取更多技术资料

    资料下载:

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1880
    北京百奥莱博科技有限公司
    2023年10月25日询价
    ¥2980
    北京义翘神州科技股份有限公司(Sino Biological Inc.)
    2026年01月26日询价
    ¥1293.50
    福因德科技(武汉)有限公司
    2025年07月14日询价
    ¥1176
    武汉益普生物科技有限公司
    2025年07月12日询价
    ¥1380
    湖北艾普蒂生物工程有限公司
    2025年11月14日询价
    Human VEGFD His标签重组血管内皮生长因子D(VEGF-D)
    ¥1855